| Net Cash Provided by (Used in) Operating Activities |
$23,998,385 |
USD |
-168% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$14,653,176 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
9,797,360 |
shares |
-5% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$9,345,209 |
USD |
-177% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$9,978,386 |
USD |
-77% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$5,268,316 |
USD |
-4% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$800,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$800,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
$17,223,625 |
USD |
-21% |
Q3 2025 |
Q3 2025 |